BHG - Bright Health Group, Inc.
NYSE
->
Healthcare
->
Healthcare Plans
Minneapolis,
United States
Type: Equity
BHG price evolution
BHG
| (in millions $) | 31 Mar 2023 | 31 Jan 2023 | 30 Sep 2022 | 30 Jun 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $382.51 | $466.32 | $1605.53 | $1427.52 |
| Short term investments | $12.11 | $13.21 | $299.9 | $833.92 |
| Net receivables | $125.24 | $99.18 | $355.26 | $540.98 |
| Inventory | ||||
| Total current assets | $3771.41 | $134.84 | $2637.9 | $3160.41 |
| Long term investments | $3.82 | $5.4 | $865.68 | $861.67 |
| Property, plant & equipment | $40.75 | $42.6 | $47.94 | $47.94 |
| Goodwill & intangible assets | $1002.36 | $1009.16 | $1024.55 | $1151.7 |
| Total noncurrent assets | $1076.59 | $1094.42 | $1974.23 | $2100.65 |
| Total investments | $15.93 | $18.61 | $1165.57 | $1695.6 |
| Total assets | $4848.01 | $4665.05 | $4612.13 | $5261.06 |
| Current liabilities | ||||
| Accounts payable | $492.1 | $67.85 | $2395.36 | $3018.3 |
| Deferred revenue | $139.42 | $0.24 | $195.89 | $56.87 |
| Short long term debt | $303.95 | $303.95 | $303.95 | |
| Total current liabilities | $4011.88 | $371.8 | $3251.36 | $3631.05 |
| Long term debt | ||||
| Total noncurrent liabilities | $32.19 | $36.67 | $33.12 | $36.09 |
| Total debt | $303.95 | $303.95 | $303.95 | |
| Total liabilities | $4044.07 | $3945.13 | $3284.48 | $3667.14 |
| Shareholders' equity | ||||
| Retained earnings | -$3331.41 | -$3156.39 | -$2476.82 | -$2170.75 |
| Other shareholder equity | -$2.24 | -$4.43 | -$81.92 | -$50.39 |
| Total shareholder equity | -$339.99 | -$200.49 | $369.14 | $681.98 |
| (in millions $) | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $466.32 | $1061.18 | $488.37 | $522.91 |
| Short term investments | $13.21 | $193.84 | $499.93 | |
| Net receivables | $99.18 | $113.47 | $60.52 | $0.79 |
| Inventory | ||||
| Total current assets | $134.84 | $1660.2 | $1179.81 | $648.6 |
| Long term investments | $5.4 | $675.19 | $175.18 | $115.35 |
| Property, plant & equipment | $42.6 | $38.34 | $12.26 | $17.26 |
| Goodwill & intangible assets | $1009.16 | $1179 | $415.25 | |
| Total noncurrent assets | $1094.42 | $1938.14 | $631 | $171.75 |
| Total investments | $18.61 | $869.03 | $675.1 | |
| Total assets | $4665.05 | $3598.34 | $1810.8 | $820.36 |
| Current liabilities | ||||
| Accounts payable | $67.85 | $1867.29 | $494.81 | $33.14 |
| Deferred revenue | $0.24 | $53.3 | $34.63 | $16 |
| Short long term debt | $303.95 | $155 | ||
| Total current liabilities | $371.8 | $2282.82 | $565.28 | $194.9 |
| Long term debt | ||||
| Total noncurrent liabilities | $36.67 | $41.99 | $28.58 | $888.83 |
| Total debt | $303.95 | $155 | ||
| Total liabilities | $3945.13 | $2324.81 | $593.86 | $211.73 |
| Shareholders' equity | ||||
| Retained earnings | -$3156.39 | -$1700.85 | -$515.99 | -$267.55 |
| Other shareholder equity | -$4.43 | -$3.33 | $2.43 | $0.98 |
| Total shareholder equity | -$200.49 | $1145.12 | -$503.67 | $608.62 |
| (in millions $) | 31 Mar 2023 | 31 Dec 2022 | 30 Sep 2022 | 30 Jun 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $756.34 | $551.42 | $1632.29 | $1576.63 |
| Cost of revenue | $688.51 | $519.29 | $1456.86 | $1398.17 |
| Gross Profit | $67.83 | $32.13 | $175.43 | $178.46 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $140.32 | $185.73 | $297.44 | $413.32 |
| Total operating expenses | $153.57 | $218.21 | $428.13 | $426.55 |
| Operating income | -$85.75 | -$186.08 | -$252.69 | -$248.09 |
| Income from continuing operations | ||||
| EBIT | -$165.97 | -$677.41 | -$299.4 | -$271.43 |
| Income tax expense | $1.26 | -$4.23 | $1.76 | $2.9 |
| Interest expense | $7.79 | $6.39 | $4.91 | $0.34 |
| Net income | ||||
| Net income | -$175.01 | -$679.57 | -$306.07 | -$274.67 |
| Income (for common shares) | -$186.91 | -$691.18 | -$315.75 | -$284.13 |
| (in millions $) | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 | 30 Dec 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2412.03 | $4029.39 | $1207.32 | $280.67 |
| Cost of revenue | $2206.24 | $3953.67 | $1047.3 | $224.39 |
| Gross Profit | $205.79 | $75.72 | $160.02 | $56.29 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $632.03 | $1238.39 | $409.33 | $179.89 |
| Total operating expenses | $828.03 | $1273.87 | $417.62 | $405.41 |
| Operating income | -$622.25 | -$1198.16 | -$257.6 | -$124.74 |
| Income from continuing operations | ||||
| EBIT | -$1439.04 | -$1203.43 | -$257.6 | -$124.74 |
| Income tax expense | $3.68 | -$26.52 | -$9.16 | |
| Interest expense | $12.82 | $7.96 | ||
| Net income | ||||
| Net income | -$1455.54 | -$1184.86 | -$248.44 | -$125.34 |
| Income (for common shares) | -$1495.23 | -$1184.86 | -$248.44 | -$125.34 |
| (in millions $) | 31 Mar 2023 | 31 Jan 2023 | 30 Sep 2022 | 30 Jun 2022 |
|---|---|---|---|---|
| Net income | -$175.01 | -$306.07 | -$274.67 | |
| Operating activities | ||||
| Depreciation | $9.89 | $13.9 | $13.23 | |
| Business acquisitions & disposals | $1.37 | |||
| Stock-based compensation | $33.32 | $24.12 | $20.22 | |
| Total cash flows from operations | -$615.02 | -$614.88 | $241.91 | |
| Investing activities | ||||
| Capital expenditures | -$1.86 | -$6.42 | -$9.66 | |
| Investments | $687.28 | $494.86 | -$308.8 | |
| Total cash flows from investing | $686.79 | -$429.72 | $488.43 | -$318.46 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0 | $0.64 | $0.41 | |
| Net borrowings | $303.95 | |||
| Total cash flows from financing | -$1.8 | $1066.37 | $304.45 | -$1.48 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $69.96 | $871.14 | $178.01 | -$78.03 |
| (in millions $) | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 |
|---|---|---|---|---|
| Net income | -$1184.86 | -$248.44 | -$125.34 | |
| Operating activities | ||||
| Depreciation | $35.48 | $8.29 | $1.13 | |
| Business acquisitions & disposals | -$431.79 | -$230.33 | ||
| Stock-based compensation | $68.42 | $5.45 | ||
| Total cash flows from operations | $82.06 | -$57.24 | -$8.21 | |
| Investing activities | ||||
| Capital expenditures | -$30.41 | -$6.47 | -$0.79 | |
| Investments | -$90.69 | -$452.94 | ||
| Total cash flows from investing | -$429.72 | -$552.89 | -$689.74 | -$94.64 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $898.72 | $1.24 | $424.06 | |
| Net borrowings | $151.61 | |||
| Total cash flows from financing | $1066.37 | $1043.64 | $712.44 | $424.06 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $871.14 | $572.81 | -$34.54 | $321.21 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $4.52B |
|---|---|
| EBITDA | N/A |
| EBIT | -$1.41B |
| Net Income | -$1.44B |
| Revenue Q/Q | -58.80% |
| Revenue Y/Y | -9.49% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | -29.62% |
| ROE | -1.12K% |
| Debt/Equity | -19.68 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.94 |
| Quick ratio | 0.94 |